NCT05375812 NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
| NCT ID | NCT05375812 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Neurological Disorders and Stroke (NINDS) |
| Condition | Gulf War Illness |
| Study Type | OBSERVATIONAL |
| Enrollment | 85 participants |
| Start Date | 2023-04-16 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 85 participants in total. It began in 2023-04-16 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Gulf War illness (GWI) affects up to 210,000 U.S. veterans who served in the Middle East during the Gulf War in 1990-1991. Symptoms include fatigue, muscle and joint pain, forgetfulness, headaches, rashes, and sleep disturbances. Routine exams cannot determine the cause of GWI. Researchers need more information to understand this disease. Objective: This natural history study will look for differences in Gulf War veterans who experienced GWI and those who did not. Eligibility: Gulf War veterans with GWI. Healthy Gulf War veterans who do not have GWI are also needed. Design: Participants will stay in the NIH Clinical Center as an inpatient for 2 weeks. They will undergo many tests. Blood will be drawn many times throughout the study. Participants will also give urine, saliva, and stool samples. Scans to measure the brain, leg muscles, bone density and body mass will be done. They will have an exercise stress test and muscle strength tests. They will have a sleep study. They will have tests to look at how well the brain, heart and lungs are working. Participants will sleep in a specialized room that measures the amount of oxygen they use and the carbon dioxide they produce on four consecutive nights. A sample of fluid will be collected from inside the spine. Participants will take many surveys. Some will ask about their activities. Some will be about emotional and mental health. Some will be about thinking, memory, and behavior. Optional tests include other imaging scans and testing the autonomic nervous system. Samples of skin and muscle may be taken. After discharge, participants will wear activity monitors for 14 days. They will keep a diary of their symptoms, including fatigue, pain, and sleep, while wearing the monitors.
Eligibility Criteria
* INCLUSION CRITERIA: Inclusion criteria for all veterans: * Ability to provide informed consent * Stated willingness to comply with all study procedures and availability for the duration of the study * Age 48-70 at time of enrollment into VA IN-DEPTH Study * Veterans who were deployed to Gulf Region ODS/S between August 1990 - June 1991. * Self-reported completion of at least the seventh grade of school. * Fluency in speaking, reading, and understanding English. * Underwent screening as part of the VA IN-DEPTH study and were unanimously determined to be eligible by the IN-DEPTH Adjudication Committee. * Agree not to smoke in the 4 hours prior to CPET procedure EXCLUSION CRITERIA: Exclusion criteria for all veterans: * Current or past psychotic disorder including depression with psychosis, bipolar disorder with psychotic symptoms and schizophrenia * Current DSM-5-defined major depression disorder, generalized anxiety disorder, posttraumatic stress disorder, panic disorder, or obsessive-compulsive disorder unless managed for more than six months with a stable treatment regimen * Current or past substance use disorder within last five years as diagnosed on the Structured Clinical Interview for DSM-5 (SCID-5). Prior or prescription marijuana use within the past five years will not be an exclusion. * Current suicidal ideation * History of head injury leading to moderate or severe traumatic brain injury, as detailed by loss of consciousness for greater than 30 minutes, a Glasgow Coma Score of 12 or less at the time of injury, post-traumatic amnesia greater than one day, or brain-scan changes related to a head injury. Persons having a history of mild TBI (mTBI) will not be excluded. * Women who are pregnant, breastfeeding, or are within one-year post-partum. * Current or previous malignancy. A history of malignancy that has fully resolved with surgical resection only (e.g. no chemotherapy, radiation therapy, or immunotherapy) will be allowed. * Current systemic immunologic disorders (e.g. Type 1 diabetes, rheumatoid arthritis). Local immunological disorder (e.g. atopic dermatitis, stable autoimmune thyroid disease) and allergic disorders will be allowed. * Current or previous long-term immune suppressive therapy. Systemic steroid use, even short-term, must not have been used within the month prior to enrollment * Any medical condition that would make the study procedures risky for the participant (e.g. congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, severe osteoarthritis, exercise-induced angina and poorly controlled asthma). * Active participation in a clinical protocol (e.g. anti-inflammatory drug intervention study) which includes an intervention that may affect the results of the current study. * Inability to perform the bicycling exercise task. (e.g. coronary artery disease, not having a lower limb, disabling stroke) * Not willing to allow for research data and samples to be shared broadly with other researchers. * Symptom severity that makes it impossible for the volunteer to travel to NIH for extended inpatient evaluation * Use of medications with a high-risk for withdrawal-related complications (i.e. long-acting opiates or benzodiazepines). Additional Exclusion criteria for participants undergoing TMS: \- Pacemaker, implanted pump, stimulator, cochlear implant or metal objects inside the eye or skull. Participants with unconfirmed metal may have further evaluation to rule out metal in the eye or skull. Participants without metal after evaluation may proceed to TMS. \- A personal history of seizure disorder Additional Exclusion criteria for participants undergoing MRI: \- Metal in the body which would make having an MRI scan unsafe, such as pacemakers, stimulators, pumps, aneurysm clips, metallic prostheses, artificial heart valves, cochlear implants or shrapnel fragments, or having a history of being a welder or metal worker, since small metal fragments may be in the eye. Participants with unconfirmed metal may have further evaluation to rule out metal in the eye or skull. Participants without metal after evaluation may proceed to MRI. * Substantial claustrophobia * Inability to lie on back for up to 2 hours Additional Exclusion criteria for Healthy Veteran Controls: \- Meets modified Kansas criteria for GWI.
Contact & Investigator
Brian T Walitt, M.D.
PRINCIPAL INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
Frequently Asked Questions
Who can join the NCT05375812 clinical trial?
This trial is open to participants of all sexes, aged 48 Years or older, up to 70 Years, studying Gulf War Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05375812 currently recruiting?
Yes, NCT05375812 is actively recruiting participants. Contact the research team at angelique.gavin@nih.gov for enrollment information.
Where is the NCT05375812 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT05375812 clinical trial?
NCT05375812 is sponsored by National Institute of Neurological Disorders and Stroke (NINDS). The principal investigator is Brian T Walitt, M.D. at National Institute of Neurological Disorders and Stroke (NINDS). The trial plans to enroll 85 participants.